Mental Health Clinics in Grand Haven, MI Accepting Medicare
45 Mental Health Clinics found. Showing 41 - 45
 Psychological Health Consultants Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1703 S Despelder St, Grand Haven, MI 49417 Phone: 616-842-1277 Fax: 616-842-4190 |
Start And Associates Psychological Support, Llc Community/Behavioral Health Agency Medicare: Medicare Enrolled Practice Location: 320 Columbus Ave, Grand Haven, MI 49417 Phone: 616-607-4476 Fax: 616-935-7177 |
Out Side In, Inc. Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 12511 152nd Avenue, Grand Haven, MI 49417 Phone: 616-844-0906 |
The Shoreline Center Llc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 16925 Ability Way, Grand Haven, MI 49417 Phone: 616-935-7606 Fax: 616-935-7607 |
Meghan Southwell Llc Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1703 S Despelder St, Grand Haven, MI 49417 Phone: 616-402-3433 |
News Archive
First mobile application is now available for clinicians to diagnose bleeding disorders
Novo Nordisk announced today the availability of Coags Uncomplicated – the first mobile application to assist in the diagnosis of bleeding disorders – created in partnership with Craig Kessler, MD, Professor of Medicine and Pathology and Director of the Coagulation Laboratory, Georgetown University Hospital, Lombardi Comprehensive Cancer Center.
Sun exposure may have an anti-melanoma effect
Italian researchers have found a link between vitamin D and the risk of developing a melanoma and they say that individuals with certain variants in a vitamin D-related gene, called BsmI, may be at an increased risk of developing melanoma.
Scientists discover simple blood test for accurate diagnoses of liver damage
Scientists have discovered that the presence of specific proteins in the blood are indicative of early liver cell damage and can determine the point at which cell death occurred, the type of cell death, and the extent of any damage. This could lead to liver damage being assessed faster and more accurately in the future information which could prove valuable when treating people following drug overdoses.
Lundbeck invests in Ossianix to focus on biotherapeutics for CNS disorders
Ossianix, Inc. today announced a strategic investment by H. Lundbeck A/S in the form of a Convertible Promissory Note. The proceeds from Lundbeck's investment is expected to allow Ossianix to generate biopharmaceuticals for the treatment of nervous system disorders by utilizing Ossianix's proprietary single domain antibody platform modeled on the shark vNAR structure.
› Verified 2 days ago